Home › NDC Lookup › RxCUI directory › RxCUI 2644891

1.1 ML elranatamab-bcmm 40 MG/ML Injection [Elrexfio] — RxCUI 2644891

Name: 1.1 ML elranatamab-bcmm 40 MG/ML Injection [Elrexfio] (RxCUI 2644891)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2644891 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2644891

Official name1.1 ML elranatamab-bcmm 40 MG/ML Injection [Elrexfio]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known as1.1 ML Elrexfio 40 MG/ML Injection; ELREXFIO 44 MG in 1.1 ML Injection; Elrexfio 44 MG per 1.1 ML Injection

FDA products mapped3

Package NDCs mapped3

Reported Medicaid activity (SDUD)74 prescriptions · 5 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How 1.1 ML elranatamab-bcmm 40 MG/ML Injection [Elre... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 1.1 ML elranatamab-bcmm 40 MG/ML Injection [Elrexfio] RxCUI 2644891 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Elranatamab 2644880 IN
- Elranatamab-bcmm 2644881 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Elrexfio 2644887 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Elranatamab Injection 2644884 SCDF
- Elranatamab-bcmm Injection 2646514 SCDFP
- Elranatamab Injectable Product 2644883 SCDG
- Elranatamab-bcmm Injectable Product 2660456 SCDGP
- Elranatamab Injection [Elrexfio] 2644890 SBDF
- Elranatamab-bcmm Injection [Elrexfio] 2654930 SBDFP
- Elrexfio Injectable Product 2644889 SBDG
- Injection 1649574 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 1.1 ML elranatamab-bcmm 40 MG/ML Injection 2644885 SCD
- Elranatamab-bcmm 40 MG/ML 2644882 SCDC
- Elranatamab-bcmm 40 MG/ML [Elrexfio] 2644888 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

1.1 ML elranatamab-bcmm 40 MG/ML Injection SCD · 2644885
Elranatamab-bcmm 40 MG/ML SCDC · 2644882
Elranatamab Injection SCDF · 2644884
Elranatamab-bcmm Injection SCDFP · 2646514
Elranatamab Injectable Product SCDG · 2644883
Elranatamab-bcmm Injectable Product SCDGP · 2660456

Brand-Name Concepts

Elranatamab-bcmm 40 MG/ML [Elrexfio] SBDC · 2644888
Elranatamab Injection [Elrexfio] SBDF · 2644890
Elranatamab-bcmm Injection [Elrexfio] SBDFP · 2654930
Elrexfio Injectable Product SBDG · 2644889
Elrexfio BN · 2644887

📦 FDA Products & Package NDCs

3 products · 3 package NDCs

3 package NDCs map to RxCUI 2644891 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00069-2522-02	1 VIAL, SINGLE-DOSE in 1 CARTON (0069-2522-02) / 1.1 mL in...	Elrexfio	Pfizer Laboratories Div Pfizer Inc	2023-08-15
00069-4494-02	1 VIAL, SINGLE-DOSE in 1 CARTON (0069-4494-02) / 1.9 mL in...	Elrexfio	Pfizer Laboratories Div Pfizer Inc	2023-08-15
63539-0252-02	1 VIAL, SINGLE-DOSE in 1 CARTON (63539-252-02) / 1.1 mL in...	Elrexfio	U.S. Pharmaceuticals	2023-08-15

Observed labelers: Pfizer Laboratories Div Pfizer Inc (2) · U.S. Pharmaceuticals (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J1323	Inj, elranatamab-bcmm, 1 mg	2	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.